Aurobindo receives tentative approval for lamivudine from US FDA
City-based pharma major Aurobindo Pharma has received tentative approval for its lamivudine tablets, a generic AIDS drug, from US FDA under the President’s Emergency Plan for AIDS Relief, according to a release.

Orchid Pharma plans to issue US $100 million GDRs
Orchid Chemicals & Pharmaceuticals has decided to raise long term funds by way of issue of Global Depository Receipts (GDRs) of US $100 million by an additional 15 per cent Green Shoe Option to meet the further financial outlay on multi-therapeutic expansion and to reduce the interest burden.

India may ban Valdecoxib
The estimated Rs 90-crore Valdecoxib, indicated for arthritis and acute pain, may finally be on its way out in India. The National Pharmaco Vigilance Advisory Committee has recommended that the drug may be prohibited for manufacture and sale in India under the Drugs and Cosmetics Act.

Dabur aims to shoot 15 pc in oral care
Dabur India, armed with an integrated oral care brand portfolio with its Balsara acquisition, is hoping to take its marketshare in the Rs 1,900 crore oral care market to 15 per cent in the next 2-3 years.